Related Experiment Video
Updated: May 6, 2026

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
Published on: April 4, 2025
Adult height in patients with advanced CKD requiring renal replacement therapy during childhood
Jérôme Harambat1, Marjolein Bonthuis, Karlijn J van Stralen
1Due to the number of contributing authors, the affiliations are provided in the Supplemental Material.
Insights
Final height in children with end-stage renal disease (ESRD) receiving renal replacement therapy (RRT) has improved over time, though it remains suboptimal. Key factors influencing height include age at RRT initiation and treatment duration.
Area of Science:
- Pediatric Nephrology
- Growth and Development
- Renal Replacement Therapy
Background:
- Final height is a significant concern for children with end-stage renal disease (ESRD).
- Understanding factors affecting final height in these patients is crucial for improving outcomes.
Purpose of the Study:
- To describe the distribution of adult height in children who began renal replacement therapy (RRT) during childhood.
- To identify determinants of final height in a large cohort of pediatric RRT patients.
Main Methods:
- Analysis of 1612 patients from 20 European countries who started RRT before age 19 and reached final height between 1990-2011.
- Linear regression models used to assess adjusted mean final height standard deviation score (SDS) and its determinants.
Main Results:
- Median final height SDS was -1.65; 55% achieved normal adult height.
- Final height SDS significantly improved over time, from -2.06 (1990-1995) to -1.33 (2006-2011).
- Older age at RRT start, more recent RRT initiation, longer graft function time, and higher initial height SDS were associated with better final height. Congenital anomalies and metabolic disorders were linked to lower final height.
Conclusions:
- Adult height in children with ESRD on RRT has shown consistent improvement over time.
- Despite improvements, final height remains suboptimal, highlighting the need for continued research and intervention.
Background And Objectives:
Growth and final height are of major concern in children with ESRD. This study sought to describe the distribution of adult height of patients who started renal replacement therapy (RRT) during childhood and to identify determinants of final height in a large cohort of RRT children.
Design, Setting, Participants, & Measurements:
A total of 1612 patients from 20 European countries who started RRT before 19 years of age and reached final height between 1990 and 2011 were included. Linear regression analyses were performed to calculate adjusted mean final height SD score (SDS) and to investigate its potential determinants.
Results:
The median final height SDS was -1.65 (median of 168 cm in boys and 155 cm in girls). Fifty-five percent of patients attained an adult height within the normal range. Adjusted for age at start of RRT and primary renal diseases, final height increased significantly over time from -2.06 SDS in children who reached adulthood in 1990-1995 to -1.33 SDS among those reaching adulthood in 2006-2011. Older age at start of RRT, more recent period of start of RRT, cumulative percentage time on a functioning graft, and greater height SDS at initiation of RRT were independently associated with a higher final height SDS. Patients with congenital anomalies of the kidney and urinary tract and metabolic disorders had a lower final height than those with other primary renal diseases.
Conclusions:
Although final height remains suboptimal in children with ESRD, it has consistently improved over time.
More Related Videos
07:35Use of Ultra-high Field MRI in Small Rodent Models of Polycystic Kidney Disease for In Vivo Phenotyping and Drug Monitoring
Published on: June 23, 2015
08:505/6th Nephrectomy in Combination with High Salt Diet and Nitric Oxide Synthase Inhibition to Induce Chronic Kidney Disease in the Lewis Rat
Published on: July 3, 2013
Related Concept Videos
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration
Chronic Kidney Disease III: Interprofessional Care
Chronic Kidney Disease I: Introduction
Drug Dosing in Renal Diseases: Measurement of Serum Creatinine Concentration and Clearance
Acute Kidney Injury III: Clinical Manifestations
Acute Kidney Injury V: Interprofessional Care